Superoxide Dismutase Activity in Different Health Conditions
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmacology".
Deadline for manuscript submissions: closed (31 October 2021)
Special Issue Editors
Interests: oxidative stress; protein–protein interactions; metallothionein, nanoparticles; toxicology
Interests: xenobiotics; oxidative stress; dietary factors in health and disease; bioactive lipid compounds; nutritional assessment
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Superoxide dismutase (SOD) is one of the most important enzymatic antioxidants, having the ability to neutralize superoxide due to catalytic disproportionation. SOD enzymes control the levels of reactive oxygen species, limiting their potential toxicity and regulating various aspects of cell life. The impact of SOD gene polymorphisms and/or alterations in SOD expression and activity have been observed in different pathological states including familial amyotrophic lateral sclerosis, inflammatory diseases, cystic fibrosis, chronic obstructive pulmonary disease, ischemia, as well as obesity and its metabolic and cardiovascular complications, but also in degenerative processes related to aging.
The protective role of SOD isoforms (SOD1, SOD2, SOD3) and their linkage to the most prevalent diseases of modern society is a topic of increasing interest. The regulation of SOD concentration and/or activity may be a way of treating the above-mentioned diseases. Furthermore, SOD conjugates or its mimics can overcome the limitations of the free enzyme and can be used as a pharmaceutical in the treatment of different diseases.
The Special Issue “Superoxide Dismutase Activity in Different Health Conditions” will cover research topics and current review articles in this field.
Dr. Marta Kepinska
Dr. Anna Prescha
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Superoxide dismutase (SOD)
- Oxidative stress
- Antioxidant defense
- Enzyme activity
- Gene polymorphism
- SOD mimesis
- Cu,Zn-SOD
- Mn-SOD
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.